全文获取类型
收费全文 | 190929篇 |
免费 | 2107篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 1282篇 |
儿科学 | 7346篇 |
妇产科学 | 3430篇 |
基础医学 | 18332篇 |
口腔科学 | 1714篇 |
临床医学 | 14605篇 |
内科学 | 33713篇 |
皮肤病学 | 835篇 |
神经病学 | 18051篇 |
特种医学 | 9234篇 |
外科学 | 30342篇 |
综合类 | 2537篇 |
一般理论 | 15篇 |
预防医学 | 20207篇 |
眼科学 | 3083篇 |
药学 | 10319篇 |
中国医学 | 637篇 |
肿瘤学 | 17386篇 |
出版年
2023年 | 137篇 |
2022年 | 234篇 |
2021年 | 564篇 |
2020年 | 348篇 |
2019年 | 535篇 |
2018年 | 22366篇 |
2017年 | 17687篇 |
2016年 | 19866篇 |
2015年 | 1319篇 |
2014年 | 1371篇 |
2013年 | 1640篇 |
2012年 | 8113篇 |
2011年 | 22254篇 |
2010年 | 19384篇 |
2009年 | 12079篇 |
2008年 | 20451篇 |
2007年 | 22695篇 |
2006年 | 1520篇 |
2005年 | 3039篇 |
2004年 | 4154篇 |
2003年 | 5093篇 |
2002年 | 3139篇 |
2001年 | 396篇 |
2000年 | 527篇 |
1999年 | 303篇 |
1998年 | 351篇 |
1997年 | 301篇 |
1996年 | 169篇 |
1995年 | 187篇 |
1994年 | 168篇 |
1993年 | 122篇 |
1992年 | 139篇 |
1991年 | 206篇 |
1990年 | 215篇 |
1989年 | 166篇 |
1988年 | 127篇 |
1987年 | 109篇 |
1986年 | 110篇 |
1985年 | 121篇 |
1984年 | 86篇 |
1983年 | 79篇 |
1982年 | 76篇 |
1981年 | 55篇 |
1980年 | 96篇 |
1979年 | 53篇 |
1974年 | 55篇 |
1970年 | 49篇 |
1969年 | 50篇 |
1938年 | 60篇 |
1932年 | 56篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
21.
22.
Pilar Nicolás 《Hereditary cancer in clinical practice》2007,5(3):144-152
The specific characteristics of genetic data lead to ethical-legal conflicts in the framework of genetic diagnosis. Several international organisations, including UNESCO and the Council of Europe, have enacted rules referring to the use of genetic information. This paper discusses possible legal and ethical criteria that could be used in genetic testing. 相似文献
23.
24.
Sergio Barroilhet Adrián Cano-Prous Salvador Cervera-Enguix Maria João Forjaz Francisco Guillén-Grima 《Social psychiatry and psychiatric epidemiology》2009,44(12):1051-1065
Introduction
This paper presents the results of a study on the psychometric properties of an authorized Spanish version of the McMaster Family Assessment Device, a self-report measure of family functioning. 相似文献25.
Kathryn Nichol Sean P. Deeny Joseph Seif Kevin Camaclang Carl W. Cotman 《Alzheimer's & dementia》2009,5(4):287-294
BackgroundHuman studies on exercise, cognition, and apolipoprotein E (APOE) genotype show that ε4 carriers may benefit from regular physical activity.MethodsWe examined voluntary wheel-running, memory, and hippocampal plasticity in APOE ε3 and APOE ε4 transgenic mice at 10–12 months of age.ResultsSedentary ε4 mice exhibited deficits in cognition on the radial-arm water maze (RAWM), a task dependent on the hippocampus. Six weeks of wheel-running in ε4 mice resulted in improvements on the RAWM to the level of ε3 mice. Hippocampal brain-derived neurotrophic factor (BDNF) levels were similar in ε3 and ε4 mice, and after exercise BDNF was similarly increased in both ε3 and ε4 mice. In sedentary ε4 mice, tyrosine kinase B (Trk B) receptors were reduced by 50%. Exercise restored Trk B in ε4 mice to the level of ε3 mice, and in ε4 mice, exercise dramatically increased synaptophysin, a marker of synaptic function.ConclusionsOur results support the hypothesis that exercise can improve cognitive function, particularly in ε4 carriers. 相似文献
26.
FDA’S Perspectives on Cardiovascular Devices 总被引:1,自引:0,他引:1
Eric A. Chen Sonna M. Patel-Raman Kathryn O’Callaghan Matthew G. Hillebrenner 《Journal of cardiovascular translational research》2009,2(2):143-146
The Food and Drug Administration (FDA) decision process for approving or clearing medical devices is often determined by a
review of robust clinical data and extensive preclinical testing of the device. The mission statement for the Center for Devices
and Radiological Health (CDRH) is to review the information provided by manufacturers so that it can promote and protect the
health of the public by ensuring the safety and effectiveness of medical devices deemed appropriate for human use (Food, Drug
& Cosmetic Act, §903(b)(1, 2(C)), December 31, 2004; accessed December 17, 2008 ). For high-risk devices, such as ventricular assist devices (VADs), mechanical heart valves, stents, cardiac resynchronization
therapy (CRT) devices, pacemakers, and defibrillators, the determination is based on FDA’s review of extensive preclinical
bench and animal testing followed by use of the device in a clinical trial in humans. These clinical trials allow the manufacturer
to evaluate a device in the intended use population. FDA reviews the data from the clinical trial to determine if the device
performed as predicted and the clinical benefits outweigh the risks. This article reviews the regulatory framework for different
marketing applications related to cardiovascular devices and describes the process of obtaining approval to study a cardiovascular
device in a U.S. clinical trial. 相似文献
27.
28.
29.
Introduction
Although ependymoma is the third most common pediatric brain tumor, we know little about the genetic/epigenetic basis of its initiation, maintenance, or progression. This is due in part to the heterogeneity of the disease, as well as the small sample size of the cohorts analyzed in most studies. 相似文献30.
Peter Angelos 《World journal of surgery》2009,33(4):609-611